Omega Fund Management

Omega Fund Management as of Dec. 31, 2021

Portfolio Holdings for Omega Fund Management

Omega Fund Management holds 22 positions in its portfolio as reported in the December 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Nuvation Bio Class A Common Stock (NUVB) 27.6 $195M 23M 8.50
Replimune Group Common Stock (REPL) 18.3 $129M 4.8M 27.10
Imago Biosciences Common Stock 10.1 $72M 3.0M 23.71
Morphic Holding Common Stock (MORF) 8.0 $57M 1.2M 47.38
Kronos Bio Common Stock 7.3 $52M 3.8M 13.59
Gossamer Bio Common Stock (GOSS) 5.1 $36M 3.2M 11.31
Ikena Oncology Common Stock (IKNA) 4.0 $28M 2.2M 12.54
Alpine Immune Sciences Common Stock 4.0 $28M 2.0M 13.85
Immunic Common Stock 2.4 $17M 1.8M 9.57
Sana Biotechnology Common Stock (SANA) 1.8 $13M 844k 15.48
Arcutis Biothereapeutics Common Stock (ARQT) 1.8 $13M 624k 20.74
Icosavax Common Stock 1.4 $9.8M 426k 22.88
Spruce Biosciences Common Stock 1.4 $9.6M 2.2M 4.46
Theseus Pharmaceuticals Common Stock 1.3 $9.0M 712k 12.68
Paratek Pharmaceuticals Common Stock 1.3 $8.9M 2.0M 4.49
Syros Pharmaceuticals Common Stock 1.2 $8.2M 2.5M 3.26
Omega Alpha SPAC Class A Common Stock 0.7 $4.9M 501k 9.77
ESSA Pharma Common Stock (EPIX) 0.7 $4.7M 328k 14.20
Adagio Therapeutics Common Stock (IVVD) 0.6 $4.6M 633k 7.26
Checkmate Pharmaceuticals Common Stock 0.5 $3.8M 1.3M 2.87
Jounce Therapeutics Common Stock 0.3 $2.3M 276k 8.35
Immunocore Holdings Common Stock (IMCR) 0.2 $1.8M 52k 34.25